Getting serious about biosimilars

1 December 2015 0

As patents on the first generation of monoclonal antibodies begin to expire, the cancer community will need to get to grips with the unique issues involved in ensuring the safety and efficacy of copies of [more]

They are many, will we be too few?

1 May 2015 0

The European Commission is predicting that by 2020 Europe will need an additional one million clinical professionals to care for its ageing population. With many of our cancer systems already working at full capacity, this [more]

Mothers coping with cancer

1 March 2014 0

Better understanding of the impact that treating pregnant women for cancer has on their unborn child means women in this position have more options open to them, as Ainhoa Iriberri explains in this article, which [more]

UA-77507851-1